Clinical Trial Update: A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration [Phase 2]

View source ↗

Summary

A masked, placebo-controlled Phase 2 trial of iptacopan for age-related macular degeneration is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• iptacopan (iptacopan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Age-Related Macular Degeneration | Phase 2 | Status: ACTIVE_NOT_RECRUITING